
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Manipal Health Enterprises Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.

Price Band
₹590
Per Share
Lot Size
25 Shares

Minimum Investment
₹14,750

Issue Size
₹9,275.22 Cr

Face Value
₹2
Per Share
IPO Type
Book Building

Retail Quota
10%

QIB Quota
75%

NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
81.86%
Promoter Holding (Post-Issue)
72.08%
Issue Type
Book Building
ISIN
INE459N01021
We operate a pan-India network of multispecialty hospitals delivering a comprehensive range of care services from outpatient services to complex tertiary and quaternary interventions. As of September 30, 2025, we operated 38 hospitals (48 hospitals on a pro forma basis) with 10,761 licensed beds (12,367 licensed beds on a pro forma basis) across 14 states and union territories. We have the widest footprint in terms of presence of hospitals among private hospital chains in India as of September 30, 2025. For details, see "-Our Hospitals and Facilities" on page 238. We are the largest pan-India multispecialty hospital network by bed capacity and the second largest hospital chain by number of hospitals as of September 30, 2025 (Source: CRISIL Report). In November 2025, we commenced operations at our 49th hospital in Bengaluru (Karnataka), which increased our licensed bed capacity to 12,631 licensed beds as of December 31, 2025. For Fiscal 2025, we reported the second-highest revenue from operations of Rs.92,635.56 million (on a pro forma basis) among private hospital chains in India, and reported the third-highest revenue from operations of Rs.82,422.50 million, among private hospital chains in India.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offer of 157,233,715 equity shares of face value of Rs. 2 each ("Equity Shares") of Manipal Health Enterprises Limited ("Company" or "Issuer") for cash at a price of Rs. 590 per equity share (including a share premium of Rs. 588 per equity share) ("Offer Price") aggregating to Rs. 9275.22 Crores comprising a fresh issue of 135,619,881 equity shares of face value of Rs. 2 each aggregating to Rs. 8000.00 Crores by the company ("Fresh Issue") and an offer for sale of 21,613,834 equity shares of face value of Rs. 2 each aggregating to Rs. 1275.22 Crores by the selling shareholders, comprising an offer for sale of 10,808,861 equity shares of face value of Rs. 2 each aggregating to Rs. 637.72 Crores by Imperius Healthcare Investments Pte. Ltd., (the "Promoter Selling Shareholder"), 6,792,002 equity shares of face value of Rs. 2 each aggregating up Rs. 400.73 Crores by Manipal Education and Medical Group India Private Limited (the "Promoter Group Selling Shareholder"), 2,329,667 equity shares of face value of Rs. 2 each aggregating to Rs. 137.45 Crores by TPG SG Magazine Pte. Ltd., 792,494 equity shares of face value of Rs. 2 each aggregating to Rs. 46.76 Crores by Seventy Second Investment Company LLC, 405,791 equity shares of face value of Rs. 2 each aggregating to Rs. 23.94 Crores by Ammar SDN BHD, 264,556 equity shares of face value of Rs. 2 each aggregating to Rs. 15.61 Crores by Novo Holdings Invest Asia A/S, and 220,463 equity shares of face value of Rs. 2 each aggregating to Rs. 13.01 Crores by Phoenix Bear Investments, LLC, (collectively the "Investor Selling Shareholders") (the promoter selling shareholder, the promoter group selling shareholder and the investor selling shareholders collectively referred to as the "Selling Shareholders" and such equity shares offered by the selling shareholders ("Offered Shares") and such offer, "Offer For Sale", and together with the fresh issue, the "Offer"). This offer includes a reservation of 280,898 equity shares of face value of Rs. 2 each, aggregating up to Rs. 15 Crore (constituting up to 0.02% of the post-offer paid-up equity share capital), for subscription by eligible employees (the "Employee Reservation Portion"). The company in consultation with the brlms, may offer a discount of Rs. 56 per equity share of face value of Rs. 2 each, to eligible employees bidding in the employee reservation portion ("Employee Discount"), subject to necessary approvals as may be required. The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer would constituted 11.95% and 11.93% of the post-offer paid-up equity share capital of the company, respectively. The company, in consultation with the brlms, may consider a pre-ipo placement of equity shares, as may be permitted under applicable law, at its discretion, aggregating up to Rs.1600.00 crores prior to filing of the ("pre-ipo placement"). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (regulation) Rules, 1957, as Amended. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. The utilisation of the proceeds raised pursuant to the pre-ipo placement will be done towards the proposed objects of the offer in compliance with applicable law. prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken). Price Band: Rs. 590 per equity share of face value of Rs. 2 each. The floor price is 295 times the face value of the equity shares. Bids can be made for a minimum of 25 equity shares of face value of Rs. 2 each and in multiples of 25 equity shares of face value of Rs. 2 each thereafter. A discount of Rs. 56 per equity share is being offered to eligible employees bidding in the employee reservation portion.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
The Company was originally incorporated in Bengaluru, Karnataka as `Manipal Health Enterprises Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated February 15, 2010, issued by the RoC. Subsequently, our Company was converted to a public limited company and the name of our Company was changed to Manipal Health Enterprises Limited pursuant to a resolution passed by our Board and by its Shareholders passed on November 8, 2025 and November 20, 2025, respectively and a fresh certificate of incorporation dated December 24, 2025 was issued by the Registrar of Companies, Central Processing Centre.
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
*Subject to approvals and market conditions.